MC 313 Orotic acid, [2-14C]- Click here for Typical Certificate of Analysis |
|
| MORpure™ Delivered ≥ 98% pure with dated HPLC radiochromatogram | |
| Aqueous solution, 100 µCi/ml | |
| ≥ 45 mCi(1.665 GBq)/mmol | 10 µCi (370 kBq) $1240 |
| NextGen V-Vial | 50 µCi (1.85 MBq) $3970 |
| M.W. 156.1 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 668 Orotic acid, [5-3H]- Click here for Typical Certificate of Analysis |
|
| MORpure™ Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| Ethanol:water (1:1) solution, 1 mCi/ml | |
| ≥ 10 Ci(0.37 TBq)/mmol | 250 µCi (9.25 MBq) $1970 |
| NextGen V-Vial | 1 mCi (37 MBq) $2600 |
| M.W. 156.1 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 668W Orotic acid, [5-3H]- Click here for Typical Certificate of Analysis |
|
| MORpure™ Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| Aqueous solution, 1 mCi/ml | 250 µCi (9.25 MBq) $1970 |
| ≥ 10 Ci(0.37 TBq)/mmol | 1 mCi (37 MBq) $2600 |
| NextGen V-Vial | |
| M.W. 156.1 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 308 Orotic acid, methyl ester, [2-14C]- |
|
| MORpure™ Delivered ≥ 98% pure with dated HPLC radiochromatogram | |
| Ethanol:water (1:1) solution, 25 µCi/ml | |
| ≥ 45 mCi(1.665 GBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial - shipped on dry ice | |
| M.W. 170.1 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
Paclitaxel |
|
| See Paclitaxel or Paclitaxel, [3H]- | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 121 Palmitic acid, [1-14C]- Click here for Typical Certificate of Analysis |
|
| CH3(CH2)14COOH | |
| MORpure™ HPLC purified, Delivered ≥ 98% pure with dated HPLC radiochromatogram | |
| Ethanol solution, 100 µCi/ml - This material requires a strong PVC overpack for shipment. See details. | |
| ≥ 40 mCi(1.48 GBq)/mmol | 50 µCi (1.85 MBq) $3970 |
| NextGen V-Vial - shipped on dry ice | 250 µCi (9.25 MBq) $4150 |
| M.W. 256.4 | 1 mCi (37 MBq) $5150 |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 845 Palmitic acid, [9,10-3H]- Click here for Typical Certificate of Analysis |
|
| CH3(CH2)5CH2CH2(CH2)7COOH | |
| MORpure™ HPLC purified, Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| Ethanol solution, 1 mCi/ml - This material requires a strong PVC overpack for shipment. See details. | |
| ≥ 30 Ci(1.11 TBq)/mmol | 1 mCi (37 MBq) $1755 |
| NextGen V-Vial - shipped on dry ice | 5 mCi (185 MBq) $1825 |
| M.W. 256.4 | 25 mCi (925 MBq) $2100 |
| 100 mCi (3.7 GBq) $3730 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 845T Palmitic acid, [9,10-3H]- Click here for Typical Certificate of Analysis |
|
| CH3(CH2)5CH2CH2(CH2)7COOH | |
| MORpure™ HPLC purified, Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| Toluene solution, 1 mCi/ml - This material requires a strong PVC overpack for shipment. See details. | |
| ≥ 30 Ci(1.11 TBq)/mmol | 1 mCi (37 MBq) $1755 |
| NextGen V-Vial - shipped on dry ice | 5 mCi (185 MBq) $1825 |
| M.W. 256.4 | 25 mCi (925 MBq) $2100 |
| 100 mCi (3.7 GBq) $3730 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 304 Palmitoyl Coenzyme A, [palmitoyl-1-14C]- Click here for Typical Certificate of Analysis |
|
| Technical Grade | |
| 0.01M Sodium acetate (pH 5.0):ethanol (1:1) solution under argon, 5 µCi/ml | |
| ≥ 40 mCi(1.48 GBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial - shipped on dry ice | |
| M.W. 1005.9 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 882 Pentagastrin, [3H]- |
|
| MORpure™ HPLC purified, Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| Ethanol solution | |
| ≥ 5 Ci(185 GBq)/mmol, 500 µCi/ml | Please Inquire for Pricing |
| NextGen V-Vial - shipped on dry ice | |
| M.W. 767.9 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 755 (-)-N6-(2-Phenylisopropyl)-adenosine, [3H]- |
|
| Click here for Typical Certificate of Analysis | |
| MORpure™ Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| Ethanol:water (1:1) solution, 1 mCi/ml | 250 µCi (9.25 MBq) $1970 |
| ≥ 10 Ci(370 GBq)/mmol | 1 mCi (37 MBq) $2780 |
| NextGen V-Vial - shipped on dry ice | |
| M.W. 385.42 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 236 Phosphamidon, [1,3-14C]- |
|
| (Dimecron, [1,3-14C]-) | |
| Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| Ethanol:water (1:1) solution, 100 µCi/ml | |
| ≥ 100 mCi(3.7 GBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial - shipped on dry ice | |
| M.W. 299.7 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 237 Phosphocreatine, [4-14C]- |
|
| (Creatine phosphoric acid, [4-14C]-) | |
| Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| Solid | Please Inquire for Pricing |
| ≥ 5 mCi(185 MBq)/mmol | |
| NextGen V-Vial - shipped on dry ice | |
| M.W. 211.1 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 528 Picolinic acid, [3H]- Click here for Typical Certificate of Analysis |
|
| (2-Pyridinecarboxylic acid, [3H]-) | |
| MORpure™ Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| Methanol solution, 1 mCi/ml | |
| ≥ 0.5 Ci(18.5 GBq)/mmol | 250 µCi (9.25 MBq) $1970 |
| NextGen V-Vial - shipped on dry ice | |
| M.W. 123.1 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 417 Pivalic acid, [1-14C]- |
|
| (CH3)3CCOOH | |
| Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| Acetone, 100 µCi/ml | |
| ≥ 45 mCi(1.665 GBq)/mmol | Please Inquire for Pricing |
| Sealed ampoule - shipped on dry ice | |
| M.W. 102.13 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 303 PMEA, [adenine-8-14C]- |
|
| See 9-(2-Phosphonyl-methoxyethyl)-adenine, [adenine-8-14C]-; Adefovir, [adenine-8-14C]- | |
| MORpure™ HPLC purified, Delivered ≥ 98% pure with dated HPLC radiochromatogram | |
| M.W. 273.19 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 703 PMEA,[adenine-2,8-3H]- |
|
| See 9-(2-Phosphonyl-methoxyethyl)-adenine, [adenine-2,8-3H]-; Adefovir, [adenine-2,8-3H]- | |
| MORpure™ HPLC purified, Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| M.W. 273.19 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 702 Podophyllotoxin, [3H]- |
|
| MORpure™ HPLC purified, Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| Ethanol solution, 1 mCi/ml | |
| ≥ 1 Ci(37-370 GBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial - shipped on dry ice | |
| M.W. 414.4 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 255 Potassium cyanide, [14C]- Discontinued |
|
| KCN | |
| Delivered ≥ 97% pure | |
| Solid | |
| ≥ 50 mCi(1.85 GBq)/mmol | |
| M.W. 65.1 | |
| NextGen V-Vial | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 243 Potassium thiocyanate, [14C]- Click here for Typical Certificate of Analysis |
|
| KSCN | |
| Delivered ≥ 97% | |
| Solid | |
| ≥ 40 mCi(1.48 GBq)/mmol | 250 µCi (9.25 MBq) $3400 |
| NextGen V-Vial | 1 mCi (37 MBq) $4030 |
| M.W. 97.2 | Larger quantity discounts available |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 263 L-Proline, [14C(U)]- Click here for Typical Certificate of Analysis |
|
| MORpure™ Delivered ≥ 98% pure with dated HPLC radiochromatogram | |
| Ethanol:water (2:98) solution, 100 µCi/ml | |
| ≥ 225 mCi(8.3 GBq)/mmol | 50 µCi (1.85 MBq) $3970 |
| NextGen V-Vial | 250 µCi (9.25 MBq) $4835 |
| M.W. 115.13 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 522 L-Proline, [2,3,4,5-3H]- Click here for Typical Certificate of Analysis |
|
| MORpure™ Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| 0.01N HCl solution, 1 mCi/ml | |
| > 60 Ci(2.22 TBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial | |
| M.W. 115.13 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 522E L-Proline, [2,3,4,5-3H]- Click here for Typical Certificate of Analysis |
|
| MORpure™ Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| Ethanol:water (2:98) solution, 5 mCi/ml | |
| > 60 Ci(2.22 TBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial | |
| M.W. 115.13 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 522M L-Proline, [2,3,4,5-3H]- |
|
| MORpure™ Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| 0.01N HCl solution, 1 mCi/ml | |
| 20 - 60 Ci(0.74 - 2.22 TBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial | |
| M.W. 115.13 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 201 Propionic acid, sodium salt, [1-14C]- Click here for Typical Certificate of Analysis |
|
| CH3CH2COONa | |
| MORpure™ Delivered ≥ 98% pure with dated HPLC radiochromatogram | |
| Ethanol solution, 100 µCi/ml | 50 µCi (1.85 MBq) $3970 |
| ≥ 50 mCi(1.85 GBq)/mmol | 250 µCi (9.25 MBq) $4280 |
| NextGen V-Vial | 1 mCi (37 MBq) $5400 |
| M.W. 96.06 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 415 Propionic acid, sodium salt, [2-14C]- Click here for Typical Certificate of Analysis |
|
| CH3CH2COONa | |
| MORpure™ HPLC purified, Delivered ≥ 98% pure with dated HPLC radiochromatogram | |
| Ethanol solution, 100 µCi/ml | |
| ≥ 50 mCi(1.85 GBq)/mmol | 50 µCi (1.85 MBq) $3970 |
| NextGen V-Vial | 250 µCi (9.25 MBq) $5045 |
| M.W. 96.06 | 1 mCi (37 MBq) $6290 |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 1148 Propionyl coenzyme A, [1-14C]- Click here for Typical Certificate of Analysis |
|
| Delivered ≥ 96% pure with dated HPLC radiochromatogram | |
| 0.01M sodium acetate solution (5.0) under argon, 50 µCi/ml | Please Inquire for Pricing |
| ≥ 50 mCi(1.85-2.22 GBq)/mmol | |
| NextGen V-Vial - shipped on dry ice | |
| M.W. 823.6 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 475 Propylene oxide, [1-14C]- |
|
| Delivered ≥ 97% | |
| Neat liquid - This material requires a strong PVC overpack for shipment. See details. | Please Inquire for Pricing |
| ≥ 20 mCi(0.74 GBq)/mmol | |
| Breakseal ampoule - shipped on dry ice | |
| M.W. 58.1 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 264 Protein hydrolysate, [14C(U)]- |
|
| Isolated from algae, [14C]- | |
| Ethanol:water (2:98) solution, 100 µCi/ml | Please Inquire for Pricing |
| 40 mCi(1.48 GBq)/mgatom carbon | |
| NextGen V-Vial | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 785 Puromycin dihydrochloride, [8-3H(N)]- |
|
| (3'-[alpha-Amino-p-methoxyhydro-cinnamido] 3'-deoxy-N,N-dimethyl-adenosine dihydrochloride, [8-3H(N)]-) | |
| MORpure™ HPLC purified, Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| Ethanol:water (1:1) solution, 500 µCi/ml | |
| ≥ 5 Ci(185 GBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial - shipped on dry ice | |
| M.W. 544.4 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
